K292-2061 Screening compound: 4-{4-oxo-2-[({[4-(propan-2-yl)phenyl]carbamoyl}methyl)sulfanyl]-3H,4H-thieno[3,2-d]pyrimidin-3-yl}-N-[2-(4-sulfamoylphenyl)ethyl]butanamide

K292-2061 Screening compound: 4-{4-oxo-2-[({[4-(propan-2-yl)phenyl]carbamoyl}methyl)sulfanyl]-3H,4H-thieno[3,2-d]pyrimidin-3-yl}-N-[2-(4-sulfamoylphenyl)ethyl]butanamide
K292-2061 Screening compound: 4-{4-oxo-2-[({[4-(propan-2-yl)phenyl]carbamoyl}methyl)sulfanyl]-3H,4H-thieno[3,2-d]pyrimidin-3-yl}-N-[2-(4-sulfamoylphenyl)ethyl]butanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound K292-2061
4-{4-oxo-2-[({[4-(propan-2-yl)phenyl]carbamoyl}methyl)sulfanyl]-3H,4H-thieno[3,2-d]pyrimidin-3-yl}-N-[2-(4-sulfamoylphenyl)ethyl]butanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

K292-2061

Molecular Formula

C29H33N5O5S3 (C29 H33 N5 O5 S3)

Compound Name

4-{4-oxo-2-[({[4-(propan-2-yl)phenyl]carbamoyl}methyl)sulfanyl]-3H,4H-thieno[3,2-d]pyrimidin-3-yl}-N-[2-(4-sulfamoylphenyl)ethyl]butanamide

IUPAC name

4-{4-oxo-2-[({[4-(propan-2-yl)phenyl]carbamoyl}methyl)sulfanyl]-3H4H-thieno[32-d]pyrimidin-3-yl}-N-[2-(4-sulfamoylphenyl)ethyl]butanamide

SMILES

CC(C)c(cc1)ccc1NC(CSC(N(CCCC(NCCc(cc1)ccc1S(N)(=O)=O)=O)C1=O)=Nc2c1scc2)=O

InChI

InChI=1S/C29H33N5O5S3/c1-19(2)21-7-9-22(10-8-21)32-26(36)18-41-29-33-24-14-17-40-27(24)28(37)34(29)16-3-4-25(35)31-15-13-20-5-11-23(12-6-20)42(30,38)39/h5-12,14,17,19H,3-4,13,15-16,18H2,1-2H3,(H,31,35)(H,32,36)(H2,30,38,39)

InChI Key

YCSBVGNZSMEVQH-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15092212

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

627.81

Hydrogen Bond Acceptors Count

13.00

Hydrogen Bond Donors Count

4.00

Rotatable Bond Count

15.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

2.750

Distribution Coefficient, logD

2.749

Water Solubility, LogSw

-3.54

Polar Surface Area

124.833

Acid Dissociation Constant (pKa)

10.18

Base Dissociation Constant (pKb)

0.72

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

31.00

K292-2061 in Drug Discovery

Included in Screening Libraries

Eccentric PPI Library (11937 compounds)

Protein-Protein Interaction Library (218420 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Carbonic Anhydrase II Library (4939 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Cyclic compounds
Therapeutical areas:
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with K292-2061 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound K292-2061?
Check Price and Availability of K292-2061, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of K292-2061 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for K292-2061
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for K292-2061
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of K292-2061 available by request